4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-111241
Chief Scientific Officer sold 100,000 shares at an average $24.72 ($2,471,640)
From the SEC's structured data for this filing
Trades in this filing
Kastelein Johannes Jacob Pieter · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-21 | Sale : show line 1 in the form | −50,000 | $24.29 | $1,214,500 | 119,302 | I |
| 2025-08-22 | Sale : show line 2 in the form | −42,342 | $25.08 | $1,061,937 | 76,960 | I |
| 2025-08-22 | Sale : show line 3 in the form | −7,658 | $25.49 | $195,202 | 69,302 | I |
| Open-market sales · 100,000 sh · avg $24.72 · $2,471,640 | ||||||
Loading xslF345X05/ownership.xml…